The purpose of the Planning and Evaluation Core (P&E Core) is to monitor the progress toward the implementation of goals and objectives of the Partnership. Planning and evaluation are the ultimate responsibilities of the Pis, and Drs.
J aim e Matta (PSM) and W. Jack Pledger (MCC) will lead this core and will be responsible for monitoring progress through ongoing evaluation processes, maximizing resources, identifying novel directions forthe Partnership, and reporting progress to institutional leaders and the NCI. The P&E Core includes the Internal Advisory Committee (JAC, P&E Table 1) and the Program Steering Committee (PSC, P&E Table 4). The lAC is responsible for internal planning and evaluation (P&E Core section 1) and new project selection (P&E Core section 2). The PSC provides external review and evaluation (P&E Core section 3). The decisions made by this core will be guided by data systematically accumulated and organized by the Evaluation Process Subcommittee (EPS) (membership below). This subcommittee is a unique strength of this core as it is led by an evaluation and process expert. Dr. Susan McMillan. Dr. McMillan is the Thompson Professor of Oncology Nursing at the University of South Florida, has training in evaluation and measurement, and has served as an evaluation consultant for several federal grants over the past decades. She is external to both PSM and MCC and as such will be able to objectively direct this subcommittee to produce formal systematic evaluations.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Specialized Center--Cooperative Agreements (U54)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-SRLB-H (O1))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
H. Lee Moffitt Cancer Center & Research Institute
United States
Zip Code
Grajales-Cruz, Ariel; Baco-Viera, Francis; Rive-Mora, Ernesto et al. (2017) Primary Adrenal Angiosarcoma: A Rare and Potentially Misdiagnosed Tumor. Cancer Control 24:198-201
Gimbrone, Nicholas T; Sarcar, Bhaswati; Gordian, Edna R et al. (2017) Somatic Mutations and Ancestry Markers in Hispanic Lung Cancer Patients. J Thorac Oncol 12:1851-1856
McIntyre, Jessica; Jiménez, Julio; Rivera, Yonaira M et al. (2017) Comparison of Health Communication Channels for Reaching Hispanics About Biobanking: a Pilot Trial. J Cancer Educ :
Nepomuceno, Thales C; De Gregoriis, Giuliana; de Oliveira, Francisco M Bastos et al. (2017) The Role of PALB2 in the DNA Damage Response and Cancer Predisposition. Int J Mol Sci 18:
Reading, N Scott; Ruiz-Bonilla, José A; Christensen, Robert D et al. (2017) A patient with both methemoglobinemia and G6PD deficiency: A therapeutic conundrum. Am J Hematol 92:474-477
Matta, Jaime; Ortiz, Carmen; Encarnación, Jarline et al. (2017) Variability in DNA Repair Capacity Levels among Molecular Breast Cancer Subtypes: Triple Negative Breast Cancer Shows Lowest Repair. Int J Mol Sci 18:
Rivera, Y M; Vélez, H; Canales, J et al. (2016) When a Common Language Is Not Enough: Transcreating Cancer 101 for Communities in Puerto Rico. J Cancer Educ 31:776-783
Ortiz, Carmen; Morales, Luisa; Sastre, Miguel et al. (2016) Cytotoxicity and Genotoxicity Assessment of Sandalwood Essential Oil in Human Breast Cell Lines MCF-7 and MCF-10A. Evid Based Complement Alternat Med 2016:3696232
Schabath, Matthew B; Cress, Douglas; Munoz-Antonia, Teresita (2016) Racial and Ethnic Differences in the Epidemiology and Genomics of Lung Cancer. Cancer Control 23:338-346
Lynce, Filipa; Graves, Kristi D; Jandorf, Lina et al. (2016) Genomic Disparities in Breast Cancer Among Latinas. Cancer Control 23:359-372

Showing the most recent 10 out of 47 publications